Skip Navigation
Skip to contents




13 results

Higher Binding Affinity and In Vitro Potency of Reslizumab for Interleukin-5 Compared With Mepolizumab

Liddament , Husten J, Estephan T, Laine D, Mabon D, Pukac L, Lyons J, Clarke AW, Doyle A

  • Allergy Asthma Immunol Res.
  • 2019 Mar;11(2):291-298.
  • doi: 10.4168/aair.2019.11.2.291
Reslizumab and mepolizumab are recently approved monoclonal antibodies for the treatment of severe (uncontrolled) eosinophilic asthma. Both are effective in neutralizing the function of interleukin-5 (IL-5). This study is the...
Prescription Patterns and Burden of Pediatric Asthma in Korea

Sol IS, Kim YH, Kim SY, Choi SH, Kim JD, Kim BO, Moon JE, Kim KW, Sohn MH

  • Allergy Asthma Immunol Res.
  • 2019 Mar;11(2):280-290.
  • doi: 10.4168/aair.2019.11.2.280
PURPOSE: This study aimed to estimate the prevalence, prescription pattern and burden of pediatric asthma in Korea by analyzing the National Health Insurance (NHI) claims data. METHODS: We retrospectively analyzed the...
Intranasal Treatment With 1, 25-Dihydroxyvitamin D3 Alleviates Allergic Rhinitis Symptoms in a Mouse Model

Cho SW, Zhang YL, Ko YK, Shin JM, Lee JH, Rhee CS, Kim DY

  • Allergy Asthma Immunol Res.
  • 2019 Mar;11(2):267-279.
  • doi: 10.4168/aair.2019.11.2.267
PURPOSE: Vitamin D is a potent immunomodulator. However, its role in the pathogenesis of allergic rhinitis is unclear. METHODS: The aim of this study was to evaluate the antiallergic effect of...
A Fusion Protein of Derp2 Allergen and Flagellin Suppresses Experimental Allergic Asthma

Tan W, Zheng JH, Duong TM, Koh YI, Lee SE, Rhee JH

  • Allergy Asthma Immunol Res.
  • 2019 Mar;11(2):254-266.
  • doi: 10.4168/aair.2019.11.2.254
PURPOSE: The house dust mite (HDM) is one of the most important sources of indoor allergens and a significant cause of allergic rhinitis and allergic asthma. Our previous studies demonstrated...
Severe Cutaneous Adverse Reactions in Korean Pediatric Patients: A Study From the Korea SCAR Registry

Oh HL, Kang DY, Kang HR, Kim S, Koh YI, Kim SH, Kim MH, Suh DI, the Korean Severe Cutaneous Adverse Reactions Consortium

  • Allergy Asthma Immunol Res.
  • 2019 Mar;11(2):241-253.
  • doi: 10.4168/aair.2019.11.2.241
PURPOSE: Although severe cutaneous adverse drug reactions (SCARs) are rare, they are associated with high morbidity and mortality, and thus early diagnosis and treatment are critical for improving prognoses. However,...
Eperisone-Induced Anaphylaxis: Pharmacovigilance Data and Results of Allergy Testing

Park KH, Lee SC, Yuk JE, Kim SR, Lee JH, Park JW

  • Allergy Asthma Immunol Res.
  • 2019 Mar;11(2):231-240.
  • doi: 10.4168/aair.2019.11.2.231
PURPOSE: Eperisone is an oral muscle relaxant used in musculoskeletal disorders causing muscle spasm and pain. For more effective pain control, eperisone is usually prescribed together with nonsteroidal anti-inflammatory drugs...
Multicenter Adherence Study of Asthma Medication for Children in Korea

Kim CK, Callaway Z, Choi J, Kim HB, Kwon EM, Chang YS, Rha YH, Hong SJ, Oh JW, Kim HH, Lim DH, Kim SW, Park KS, Cho YH, Chung HL, Park HJ, Jung SG, Kang IJ, Hyun MC, Oh MY, Jung JA, Kim MS, Shim JY, Kim JT, Koh YY, KAPARD Work Group on Asthma Medication Compliance

  • Allergy Asthma Immunol Res.
  • 2019 Mar;11(2):222-230.
  • doi: 10.4168/aair.2019.11.2.222
PURPOSE: Adherence is a major component of successful medical treatment. However, non-adherence remains a barrier to effective delivery of healthcare worldwide. METHODS: Twenty healthcare facilities (secondary or tertiary hospitals) belonging to...
Phenotypes of Severe Cutaneous Adverse Reactions Caused by Nonsteroidal Anti-inflammatory Drugs

Lee SY, Nam YH, Koh YI, Kim SH, Kim S, Kang HR, Kim MH, Lee JG, Park JW, Park HK, La HO, Kim MY, Park SJ, Kwon YE, Jung JW, Kim SH, Kim CW, Yang MS, Kang MG, Lee JY, Kim JH, Kim SH, Hur GY, Jee YK, Jin HJ, Park CS, Jeong YY, Ye YM

  • Allergy Asthma Immunol Res.
  • 2019 Mar;11(2):212-221.
  • doi: 10.4168/aair.2019.11.2.212
PURPOSE: Nonsteroidal anti-inflammatory drugs (NSAIDs) are common cause of severe cutaneous adverse reactions (SCARs). The present study aimed to investigate the characteristics of SCARs induced by NSAIDs in the Korean...
Comparison Between Signature Cytokines of Nasal Tissues in Subtypes of Chronic Rhinosinusitis

Kim DK, Eun KM, Kim MK, Cho D, Han SA, Han SY, Seo Y, Lee DH, Cho SH, Kim DW

  • Allergy Asthma Immunol Res.
  • 2019 Mar;11(2):201-211.
  • doi: 10.4168/aair.2019.11.2.201
PURPOSE: Endotype in chronic rhinosinusitis (CRS) has been established in the last decade. However, the exact immunologic profile of CRS still has controversy because it has a considerable immunologic heterogeneity....
Update on the Management of Occupational Asthma and Work-Exacerbated Asthma

Lau A, Tarlo SM

  • Allergy Asthma Immunol Res.
  • 2019 Mar;11(2):188-200.
  • doi: 10.4168/aair.2019.11.2.188
Work-related asthma is the most common occupational lung disease encountered in clinical practice. In adult asthmatics, work-relatedness can account for 15%–33% of cases, but delays in diagnosis remain common and...
Lessons Learned From GWAS of Asthma

Kim KW, Ober C

  • Allergy Asthma Immunol Res.
  • 2019 Mar;11(2):170-187.
  • doi: 10.4168/aair.2019.11.2.170
Asthma is a common complex disease of the airways. Genome-wide association studies (GWASs) of asthma have identified many risk alleles and loci that have been replicated in worldwide populations. Although...
Increasing Prevalence of Allergic Rhinitis in China

Zhang Y, Zhang L

  • Allergy Asthma Immunol Res.
  • 2019 Mar;11(2):156-169.
  • doi: 10.4168/aair.2019.11.2.156
Allergic rhinitis (AR) is a critical public health, medical and economic problem in China. AR is also an important risk factor which will cause many diseases or disorders, especially in...
Does Inflammatory Endotype Change in Patients With Chronic Rhinosinusitis?

Kim DK, Kim DW

  • Allergy Asthma Immunol Res.
  • 2019 Mar;11(2):153-155.
  • doi: 10.4168/aair.2019.11.2.153
No abstract available.

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: